During the past decade, University of Kansas Cancer Center conducted 209 clinical trials. In the 10-year time frame, 209 clinical trials started and 155 clinical trials were completed, i.e. on average, 74.2% percent of trials that started reached the finish line to date. In the past 5 years, 87 clinical trials started and 74 clinical trials were completed. i.e. 85.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 137 trials, followed by "SWOG Cancer Research Network" with 77 trials sponsored, "Children's Oncology Group" with 39 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored and "NRG Oncology" with 26 trials sponsored. Other sponsors include 149 different institutions and companies that sponsored additional 79 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 230 trials as a collaborator, "NRG Oncology" with 40 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator and "Cancer and Leukemia Group B" with 9 trials as a collaborator. Other collaborators include 101 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Cancer Center" are "Breast Cancer" (21 trials), "Leukemia" (18 trials), "Prostate Cancer" (17 trials), "Lymphoma" (15 trials) and "Lung Cancer" (11 trials). Many other conditions were trialed in "University of Kansas Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Kansas Cancer Center" are "Drug" (352 trials), "Other" (188 trials), "Biological" (147 trials), "Radiation" (115 trials) and "Procedure" (112 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (96 trials), "Quality-of-Life Assessment" (63 trials), "Questionnaire Administration" (39 trials), "Carboplatin" (38 trials) and "Paclitaxel" (37 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Cancer Center" are 351 trials for "All" genders, 71 trials for "Female" genders and 36 trials for "Male" genders.

Currently, there are NaN active trials in "University of Kansas Cancer Center". 1 are not yet recruiting, 81 are recruiting, 155 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 176 completed trials in University of Kansas Cancer Center, 12 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Cancer Center, 47 "Phase 1" clinical trials were conducted, 220 "Phase 2" clinical trials and 190 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 22 trials that are defined as “Not Applicable".

University of Kansas Cancer Center has several departments that took part in Clinical trials: "University of Kansas Cancer Center" - 120 trials, "Kansas City NCI Community Oncology Research Program" - 75 trials, "University of Kansas Cancer Center-Overland Park" - 197 trials, "University of Kansas Cancer Center - North" - 191 trials, "University of Kansas Cancer Center - Lee's Summit" - 177 trials, "Radiation Oncology Practice Corporation Southwest" - 18 trials, "The University of Kansas Cancer Center, Investigational Drug Services" - 4 trials, "The University of Kansas Cancer Center - Indian Creek Campus" - 2 trials, "Kansas City Cancer Centers" - 2 trials